Interaction between dexamethasone treatment and the corticotropin stimulation test in septic shock

Annals of Pharmacotherapy

Volumn 39, Issue 2, 2005, Pages 335-338

  Bower, Amy N ^a   Oyen, Lance J ^a,b  

^a MAYO CLINIC   (United States)

^b NONE   (United States)

Author keywords

Adrenal insufficiency; Corticosteroid; Corticotropin stimulation test; Critical care

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; DEXAMETHASONE; FLUDROCORTISONE; HYDROCORTISONE;

ADRENAL INSUFFICIENCY; ADRENAL SUPPRESSION; CLINICAL TRIAL; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN TEST; DRUG DOSE REGIMEN; HUMAN; HYDROCORTISONE BLOOD LEVEL; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; SEPTIC SHOCK; SUBSTITUTION THERAPY;

EID: 12844273507     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E353     Document Type: Review

References (21)

1. Lefering R, Neugebauer EA. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med 1995;23:1294-303.
2. Cronin L, Cook DJ, Carlet J, Heyland DK, King D, Lansang MA, et al. Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 1995;23:1430-9.
3. Annane D, Bellissant E, Bollaert P, Briegel J, Keh D, Kupfer Y. Corticosteroids for treating severe sepsis and septic shock. BMJ 2004;329:480-8.
4. Minneci PC, Deans KJ, Banks SM, Eichacker PQ, Natanson C. Metaanalysis: the effects of steroids on survival and shock during sepsis depends on the dose. Ann Intern Med 2004;141:47-57.
5. Luce JM. Physicians should administer low-dose corticosteroids selectively to septic patients until an ongoing trial is completed. Ann Intern Med 2004;141:70-2.
6. Annane D, Sébille V, Troché G, Raphaël J-C, Gajdos P, Bellissant E. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000;283:1038-45.
7. Annane D, Sébille V, Charpentier C, Bollaert P-E, François B, Korach J-M, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288:862-71.
8. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-73.
9. Ten S, New M, Maclaren N. Clinical review 130: Addison's disease 2001. J Clin Endocrinol Metab 2001;86:2909-22.
10. Zaloga GP, Marik P. Endocrine and metabolic dysfunction syndromes in the critically ill. Crit Care Clin 2001;17:25-41.
11. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332:1351-62.
12. Cooper MS, Stewart PM. Current concepts: corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003;348:727-34.
13. Beishuizen A, Thijs LG. Relative adrenal failure in intensive care: an identifiable problem requiring treatment? Best Pract Res Clin Endocrinol Metab 2001;15:513-31.
14. Marik PE, Zaloga GP. Adrenal insufficiency in the critically ill: a new look at an old problem. Chest 2002;122:1784-96.
15. Annane D. Corticosteroids for septic shock. Crit Care Med 2001;29(7 suppl):S117-20.
16. Schimmer BP, Parker KL. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill, 1996:1459-85.
17. Newell-Price J, Trainer P, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocrinol Rev 1998;19:647-72.
18. Package insert. Double antibody cortisol assay. Los Angeles: Diagnostic Products, August 5, 2004.
19. Orth DN. Cushing's syndrome. N Engl J Med 1995;332:791-803.
20. Tuck ML, Sowers JR, Asp ND, Viosca SP, Berg G, Mayes DM. Mineralocorticoid response to low dose adrenocorticotropin infusion. J Clin Endocrinol Metab 1981;52:440-6.
21. Dickstein G, Shechner C, Nicholson WE, Rosner I, Shen-Orr Z, Adawi F, et al. Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test. J Clin Endocrinol Metab 1991;72:773-8.